real-world outcomes of her2 and tnbc patients recieving neoadjuvant chemotherapy
Published 3 years ago • 236 plays • Length 8:52Download video MP4
Download video MP3
Similar videos
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
1:02
evaluating the role of neoadjuvant chemotherapy and surgery in stage i tnbc
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
1:51
eleanor interim analysis: real-world study of adjuvant neratinib in her2 /hr early breast cancer
-
1:46
exploratory analysis of keynote-522: efs after neoadjuvant pembro chemo vs chemo for early tnbc
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:42
impassion031: patient-reported outcomes
-
5:34
neos: prognosis of er breast cancer pts who received neoadjuvant et with/without adjuvant chemo
-
1:25
real-world treatment patterns for her2-amplified colorectal cancer
-
3:39
checkmate 7fl: nivo vs pbo in high-risk er her2- bc with neoadjuvant chemo and adjuvant therapy
-
2:34
eleanor: real-world use of neratinib in her2 , early breast cancer
-
2:13
changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer
-
2:59
talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer